28389361|t|Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
28389361|a|The degeneration of retinal ganglion cells (RGCs) has been identified as a major problem in glaucoma. Previous studies have indicated an association between annexin A1 (ANXA1) and neuronal cell apoptosis, and RGCs apoptosis in acute ischemia-reperfusion was attributed to an increased production of IL-1β. We found that the expression and nuclear translocation of ANXA1 were upregulated in models of acute ischemia-reperfusion in RGCs in vivo. ANXA1 was found to have a promoting effect on the expression of IL-1β in primary cultured RGCs, which could be inhibited by treatment with ANXA1 shRNA or the p65 inhibitor BAY 11-7082. ANXA1 interacted with p65, and recruited it into the nucleus. Chromatin immunoprecipitation assay revealed that ANXA1 accumulated at the IL-1β gene promoter. The reduction of p65 nuclear translocation using a membrane-permeable ANXA1 peptide containing a Ser5Ala mutation led to a decrease in the expression of IL-1β, and acute ischemia-reperfusion induced RGCs apoptosis in vivo. These results indicate that in RGCs, ANXA1 increases IL-1β expression by recruiting p65 to the nucleus, which induces cell apoptosis. The obtained results may help the development of a novel treatment strategy against RGCs apoptosis in acute ischemia-reperfusion injury.
28389361	0	10	Annexin A1	T116,T121,T123	C0103403
28389361	11	32	nuclear translocation	T044	C1518440
28389361	41	62	retinal ganglion cell	T025	C0035316
28389361	63	72	apoptosis	T043	C0162638
28389361	79	106	ischemia-reperfusion injury	T037	C0349419
28389361	141	153	degeneration	T046	C0011164
28389361	157	179	retinal ganglion cells	T025	C0035316
28389361	181	185	RGCs	T025	C0035316
28389361	229	237	glaucoma	T047	C0017601
28389361	274	285	association	T080	C0439849
28389361	294	304	annexin A1	T116,T121,T123	C0103403
28389361	306	311	ANXA1	T116,T121,T123	C0103403
28389361	317	340	neuronal cell apoptosis	T043	C1660771
28389361	346	350	RGCs	T025	C0035316
28389361	351	360	apoptosis	T043	C0162638
28389361	364	369	acute	T079	C0205178
28389361	370	390	ischemia-reperfusion	T037	C0349419
28389361	436	441	IL-1β	T116,T129	C0021753
28389361	461	471	expression	T045	C1171362
28389361	476	497	nuclear translocation	T044	C1518440
28389361	501	506	ANXA1	T116,T121,T123	C0103403
28389361	512	523	upregulated	T044	C0041904
28389361	537	542	acute	T079	C0205178
28389361	543	563	ischemia-reperfusion	T037	C0349419
28389361	567	571	RGCs	T025	C0035316
28389361	572	579	in vivo	T082	C1515655
28389361	581	586	ANXA1	T116,T121,T123	C0103403
28389361	607	623	promoting effect	T052	C0033414
28389361	631	641	expression	T045	C1171362
28389361	645	650	IL-1β	T116,T129	C0021753
28389361	654	670	primary cultured	T059	C1449562
28389361	671	675	RGCs	T025	C0035316
28389361	692	701	inhibited	T080	C0311403
28389361	705	714	treatment	T169	C1522326
28389361	720	731	ANXA1 shRNA	T114	C2930586
28389361	739	764	p65 inhibitor BAY 11-7082	T109	C0969281
28389361	766	771	ANXA1	T116,T121,T123	C0103403
28389361	788	791	p65	T116,T123	C0599933
28389361	819	826	nucleus	T026	C0007610
28389361	828	863	Chromatin immunoprecipitation assay	T059	C0020980
28389361	878	883	ANXA1	T116,T121,T123	C0103403
28389361	903	913	IL-1β gene	T028	C1334112
28389361	914	922	promoter	T114,T123	C0033413
28389361	928	937	reduction	T080	C0392756
28389361	941	966	p65 nuclear translocation	T044	C1518440
28389361	975	993	membrane-permeable	T169	C0205326
28389361	994	1007	ANXA1 peptide	T116,T121,T123	C0103403
28389361	1021	1037	Ser5Ala mutation	T045	C0026882
28389361	1047	1055	decrease	T081	C0547047
28389361	1063	1073	expression	T045	C1171362
28389361	1077	1082	IL-1β	T116,T129	C0021753
28389361	1088	1093	acute	T079	C0205178
28389361	1094	1114	ischemia-reperfusion	T037	C0349419
28389361	1123	1127	RGCs	T025	C0035316
28389361	1128	1137	apoptosis	T043	C0162638
28389361	1138	1145	in vivo	T082	C1515655
28389361	1153	1160	results	T169	C1274040
28389361	1178	1182	RGCs	T025	C0035316
28389361	1184	1189	ANXA1	T116,T121,T123	C0103403
28389361	1200	1205	IL-1β	T116,T129	C0021753
28389361	1206	1216	expression	T045	C1171362
28389361	1231	1234	p65	T116,T123	C0599933
28389361	1242	1249	nucleus	T026	C0007610
28389361	1257	1264	induces	T169	C0205263
28389361	1265	1279	cell apoptosis	T043	C0162638
28389361	1294	1301	results	T169	C1274040
28389361	1338	1356	treatment strategy	T061	C0040808
28389361	1365	1369	RGCs	T025	C0035316
28389361	1370	1379	apoptosis	T043	C0162638
28389361	1383	1388	acute	T079	C0205178
28389361	1389	1416	ischemia-reperfusion injury	T037	C0349419